TIEN WONG, M.D.
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1003914151
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 720 | 23,641 | $16,581,080 | $5,283,950 | $4,191,141 |
| 2023 | 865 | 18,154 | $18,094,564 | $5,787,127 | $4,576,927 |
| 2022 | 1,116 | 16,181 | $12,431,552 | $6,262,748 | $4,947,379 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0177 | Injection, aflibercept hd, 1 mg | 6,616 | $326 | $260 |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 4,926 | $32 | $26 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 4,875 | $147 | $117 |
| 92134 | Imaging of retina | 1,802 | $42 | $32 |
| 67028 | Injection of drug into eye | 1,340 | $143 | $112 |
| 92014 | Established patient complete exam of visual system | 1,082 | $131 | $95 |
| J0178 | Injection, aflibercept, 1 mg | 862 | $823 | $655 |
| J3590 | Unclassified biologics | 305 | $2,608 | $2,076 |
| J2778 | Injection, ranibizumab, 0.1 mg | 276 | $165 | $131 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 231 | $230 | $183 |
| 92250 | Photography of the retina | 86 | $39 | $31 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 73 | $135 | $93 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | H3961 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | H3961 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.